Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V W Johnson

Showing results (41-50 of 163) with videos related to

Pageof 17
Sort By:
Molecular Neurobiology|August 28, 2020
The Crosstalk Between Pathological Tau Phosphorylation and Mitochondrial Dysfunction as a Key to Understanding and Treating Alzheimer's DiseaseSanjib Guha, Gail V W Johnson, Keith Nehrke
Journal of Alzheimer'S Disease : JAD|November 26, 2002
Tau, where are we now?Gail V W Johnson, Craig D C Bailey
Journal of Cellular Biochemistry|August 28, 2009
Phosphorylation of PPP(S/T)P motif of the free LRP6 intracellular domain is not required to activate the Wnt/beta-catenin pathway and attenuate GSK3beta activityBrandon Beagle, Kaihong Mi, Gail V W Johnson
Journal of Neurochemistry|December 21, 2004
Tissue transglutaminase contributes to disease progression in the R6/2 Huntington's disease mouse model via aggregate-independent mechanismsCraig D C Bailey, Gail V W Johnson
World Journal of Microbiology & Biotechnology|January 15, 2014
Influence of growth conditions on the accumulation of ergosterol by Rhodotorula glutinisV W Johnson, M Singh, N K Yadav
Neurobiology of Aging|September 13, 2014
BAG3 facilitates the clearance of endogenous tau in primary neuronsZhinian Lei, Corey Brizzee, Gail V W Johnson
Biorxiv : the Preprint Server for Biology|July 16, 2025
Tau Clearance Reverses Neuronal Dysfunction in Both Young and Aged <i>C. elegans</i>T Carroll, G V W Johnson, K Nehrke
Analytical Biochemistry|December 24, 2019
The role of transglutaminase 2 in mediating glial cell function and pathophysiology in the central nervous systemJacob Rudlong, Anson Cheng, Gail V W Johnson
Journal of Neurochemistry|December 9, 2004
Developmental regulation of tissue transglutaminase in the mouse forebrainCraig D C Bailey, Gail V W Johnson
Neurobiology of Aging|May 18, 2005
The protective effects of cystamine in the R6/2 Huntington's disease mouse involve mechanisms other than the inhibition of tissue transglutaminaseCraig D C Bailey, Gail V W Johnson
Pageof 17

Showing results (41-50 of 163) with videos related to

Sort By:
Pageof 17
Molecular Neurobiology|August 28, 2020
The Crosstalk Between Pathological Tau Phosphorylation and Mitochondrial Dysfunction as a Key to Understanding and Treating Alzheimer's DiseaseSanjib Guha, Gail V W Johnson, Keith Nehrke
Journal of Alzheimer'S Disease : JAD|November 26, 2002
Tau, where are we now?Gail V W Johnson, Craig D C Bailey
Journal of Cellular Biochemistry|August 28, 2009
Phosphorylation of PPP(S/T)P motif of the free LRP6 intracellular domain is not required to activate the Wnt/beta-catenin pathway and attenuate GSK3beta activityBrandon Beagle, Kaihong Mi, Gail V W Johnson
Journal of Neurochemistry|December 21, 2004
Tissue transglutaminase contributes to disease progression in the R6/2 Huntington's disease mouse model via aggregate-independent mechanismsCraig D C Bailey, Gail V W Johnson
World Journal of Microbiology & Biotechnology|January 15, 2014
Influence of growth conditions on the accumulation of ergosterol by Rhodotorula glutinisV W Johnson, M Singh, N K Yadav
Neurobiology of Aging|September 13, 2014
BAG3 facilitates the clearance of endogenous tau in primary neuronsZhinian Lei, Corey Brizzee, Gail V W Johnson
Biorxiv : the Preprint Server for Biology|July 16, 2025
Tau Clearance Reverses Neuronal Dysfunction in Both Young and Aged <i>C. elegans</i>T Carroll, G V W Johnson, K Nehrke
Analytical Biochemistry|December 24, 2019
The role of transglutaminase 2 in mediating glial cell function and pathophysiology in the central nervous systemJacob Rudlong, Anson Cheng, Gail V W Johnson
Journal of Neurochemistry|December 9, 2004
Developmental regulation of tissue transglutaminase in the mouse forebrainCraig D C Bailey, Gail V W Johnson
Neurobiology of Aging|May 18, 2005
The protective effects of cystamine in the R6/2 Huntington's disease mouse involve mechanisms other than the inhibition of tissue transglutaminaseCraig D C Bailey, Gail V W Johnson
Pageof 17